Clinical Trials Directory

Trials / Terminated

TerminatedNCT00490893

Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir

Effects of Insulin Detemir Versus Regular Insulin (Actrapid) on Hormonal Counterregulation, Cognitive Function and Symptom Perception During Hypoglycemia

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Hypoglycemia and unawareness of hypoglycemia are major problems of insulin therapy in patients with diabetes mellitus. The long acting insulin analogue Detemir has structural and physicochemical properties which differ from human insulin. The aim of the present study is to test whether this leads to altered hormone and symptom response during hypoglycemia.

Conditions

Interventions

TypeNameDescription
DRUGDetemir

Timeline

Start date
2006-03-01
Completion
2006-12-01
First posted
2007-06-25
Last updated
2007-06-25

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00490893. Inclusion in this directory is not an endorsement.